Prognostic Value of Changes in Preoperative and Postoperative Serum CA19-9 Levels in Gastric Cancer
- PMID: 33014781
- PMCID: PMC7461783
- DOI: 10.3389/fonc.2020.01432
Prognostic Value of Changes in Preoperative and Postoperative Serum CA19-9 Levels in Gastric Cancer
Abstract
Objective: The prognostic significance of serum CA19-9 levels in gastric cancer patients remains a matter debate. The aim of this study was to determine the prognostic value of changes in preoperative and postoperative serum CA19-9 levels in patients with gastric cancer. Methods: A total of 1,046 gastric cancer patients who underwent curative gastrectomy in West China Hospital of Sichuan University from January 2011 to December 2016 were analyzed retrospectively. Patients were categorized by minimum P-value using X-tile, while the baseline confounders for CA19-9 changes were balanced through propensity score matching (PSM). The relationships between CA19-9 changes and other clinicopathologic features were measured. Univariate and multivariate analysis were performed to explore the risk factors associated with survival outcomes. Results: We included 653 patients. Changes in CA19-9 levels significantly correlated with age, tumor size, macroscopic type, histological grade, T stage and TNM stage. Kaplan-Meier curves revealed that patients with CA19-9 changes <20% had significant better overall survival than those with changes more than 20% (p < 0.001); Cox regression analysis revealed the CA19-9 change (p = 0.010), gender (p = 0.031), histological grade (p = 0.036) and TNM stage (p < 0.001) were independent risk factors for survival after PSM. Stratification analysis indicated that patients with CA19-9 change more than 20% had worse prognosis that those with CA19-9 change no more than 20% in male (p = 0.002), poorly differentiated or undifferentiated type (p = 0.031) and TNM stage III (p = 0.006). Conclusion: Changes in preoperative and postoperative serum CA19-9 levels were closely associated with clinicopathological traits and was an independent prognostic factor in gastric cancer patients. This parameter may be a reliable marker for prediction of survival.
Keywords: CA19-9; gastrectomy; gastric cancer; overall survival; prognosis.
Copyright © 2020 Song, Liu, Yang, Zhang, Chen, Zhao, Chen, Yang, Zhou and Hu.
Figures



Similar articles
-
Is Preoperative Fibrinogen Associated with the Survival Prognosis of Gastric Cancer Patients? A Multi-centered, Propensity Score-Matched Retrospective Study.World J Surg. 2020 Jan;44(1):213-222. doi: 10.1007/s00268-019-05191-9. World J Surg. 2020. PMID: 31637507
-
Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?Ann Surg Oncol. 2018 Sep;25(9):2703-2712. doi: 10.1245/s10434-018-6634-z. Epub 2018 Jul 3. Ann Surg Oncol. 2018. PMID: 29971670
-
Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma.Oncotarget. 2016 Jun 7;7(23):35423-36. doi: 10.18632/oncotarget.8770. Oncotarget. 2016. PMID: 27097114 Free PMC article.
-
Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer.Gastric Cancer. 2000 Dec;3(4):177-186. doi: 10.1007/pl00011715. Gastric Cancer. 2000. PMID: 11984734
-
Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer.World J Gastrointest Oncol. 2019 Jan 15;11(1):17-27. doi: 10.4251/wjgo.v11.i1.17. World J Gastrointest Oncol. 2019. PMID: 30984347 Free PMC article.
Cited by
-
Efficient plasma metabolic fingerprinting as a novel tool for diagnosis and prognosis of gastric cancer: a large-scale, multicentre study.Gut. 2023 Nov;72(11):2051-2067. doi: 10.1136/gutjnl-2023-330045. Epub 2023 Jul 17. Gut. 2023. PMID: 37460165 Free PMC article.
-
Multi-modal analysis for accurate prediction of preoperative stage and indications of optimal treatment in gastric cancer.Radiol Med. 2023 May;128(5):509-519. doi: 10.1007/s11547-023-01625-6. Epub 2023 Apr 28. Radiol Med. 2023. PMID: 37115392
-
Prognostic value of IGFBP2 in various cancers: a systematic review and meta-analysis.Cancer Med. 2022 Aug;11(16):3035-3047. doi: 10.1002/cam4.4680. Epub 2022 May 11. Cancer Med. 2022. PMID: 35546443 Free PMC article.
-
The Survival Relationship between Preoperative Inflammation Markers and Patients with Special Pathological Types of Gastric Cancer.Can J Gastroenterol Hepatol. 2022 Mar 18;2022:5715898. doi: 10.1155/2022/5715898. eCollection 2022. Can J Gastroenterol Hepatol. 2022. PMID: 35340978 Free PMC article.
-
Molecular and Circulating Biomarkers of Gastric Cancer.Int J Mol Sci. 2022 Jul 8;23(14):7588. doi: 10.3390/ijms23147588. Int J Mol Sci. 2022. PMID: 35886934 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous